COMMUNIQUÉS West-GlobeNewswire

InBrain Pharma to Present Positive Results from Its DIVE-I Phase I/II Clinical Trial for Parkinson’s Disease at the Congress of Parkinson’s Disease and Movement Disorders from September 27 to October 1 in Philadelphia

25/09/2024 - 15:00

Lille, September 25, 2024 - InBrain Pharma, a biopharmaceutical company specialized in neurodegenerative diseases, will present the positive results of its Phase I/II DIVE-I clinical trial for Parkinson’s disease at the [...]

Sanner Group acquires Gilero to expand its global medical device offering

25/09/2024 - 15:00

Sanner Group acquires Gilero to expand its global medical device offering Acquisition drives Sanner Group’s mission to offer a suite of world leading development and manufacturing services for its customers across the [...]

SIRONA BIOCHEM Poised for Profitability in 2025 with Anti-Aging Product Rollout

25/09/2024 - 15:00

VANCOUVER, British Columbia, Sept. 25, 2024 (GLOBE NEWSWIRE) -- Sirona Biochem Corp . (TSX-V: SBM) (FSE: ZSB) (OTC: SRBCF) (“ Sirona ” or the “ Company ”) provides the following update: Dear Shareholders, We are [...]

GoLiver Therapeutics is the winner of the France 2030 “innovation in Biotherapies and Bioproduction” call for its GOCLINICALS project, dedicated to a novel stem cell-based liver therapy

25/09/2024 - 15:00

Press release GoLiver Therapeutics has been awarded €1.6m from France 2030 to progress its first biomedicine, developed from pluripotent stem cells, into the clinic for the treatment of severe liver failures. Nantes, [...]

QHSLab Secures Grant Sponsorship from a Global Leader in Consumer Health to Advance Digital Medicine Tools for Allergy Management in the Primary Care Setting

25/09/2024 - 15:00

WEST PALM BEACH, FL, Sept. 25, 2024 (GLOBE NEWSWIRE) -- QHSLab, Inc. (the "Company") (OTCQB: USAQ), a leader in digital health and point-of-care technologies designed to empower clinicians with proactive, value-based [...]

Kronos Bio to Present Data at ACR Convergence 2024 to Support p300 KAT Inhibition as an Approach to Anti-Inflammatory Therapy

25/09/2024 - 14:55

– Through selective inhibition of proinflammatory transcription, p300 KAT inhibition modulates the activity and function of multiple pro-inflammatory signaling pathways that drive chronic inflammatory diseases – – Oral [...]

GRI Bio (NASDAQ: GRI) to Participate in a Virtual Investor CEO Connect Segment

25/09/2024 - 14:45

Live video webcast on Wednesday, October 2 nd at 12:00 PM ET LA JOLLA, CA, Sept. 25, 2024 (GLOBE NEWSWIRE) -- GRI Bio, Inc. (NASDAQ: GRI) (“GRI Bio,” “we,” “our,” or the “Company”), a biotechnology company advancing an [...]

Kairos Pharma Enters Agreement with PreCheck Health Services to Develop Biomarkers to Identify Patients Responsive to ENV105 to Target Cancer Drug Resistance in Prostate and Lung Cancer Patients

24/09/2024 - 22:20

LOS ANGELES, Sept. 24, 2024 (GLOBE NEWSWIRE) -- Kairos Pharma Ltd. (NYSE American: KAPA), a clinical-stage biopharmaceutical company, announces a groundbreaking collaboration with PreCheck Health Services Inc., a CLIA- [...]

Precision Optics Corporation Schedules Fourth Quarter and Fiscal Year 2024 Conference Call for Monday, September 30, 2024

24/09/2024 - 22:15

GARDNER, Mass., Sept. 24, 2024 (GLOBE NEWSWIRE) -- Precision Optics Corporation, Inc. (Nasdaq: POCI) (the "Company"), a leading designer and manufacturer of advanced optical instruments for the medical and defense/ [...]

LifeMD® Declares Quarterly Dividend on Series A Cumulative Perpetual Preferred Stock

24/09/2024 - 22:05

NEW YORK, Sept. 24, 2024 (GLOBE NEWSWIRE) -- LifeMD, Inc. (Nasdaq: LFMD), a leading provider of virtual primary care services, today announced that its Board of Directors has authorized a cash dividend to holders of the [...]

Lyell Immunopharma Announces Participation in Goldman Sachs Cell Therapy Day

24/09/2024 - 22:05

SOUTH SAN FRANCISCO, Calif., Sept. 24, 2024 (GLOBE NEWSWIRE) -- Lyell Immunopharma, Inc. (Nasdaq: LYEL), a clinical‑stage T-cell reprogramming company advancing a diverse pipeline of cell therapies for patients with [...]

Trinity Biotech Announces Acquisition of Metabolomics Diagnostics to Grow Presence in Maternal Health Market

24/09/2024 - 22:05

-Metabolomics Diagnostics, a deep-tech machine learning diagnostic platform developer, has developed an innovative test, PrePsia, to accurately predict the risk of preeclampsia in pregnant women- -The PrePsia test can [...]

Wave Life Sciences Announces Proposed Public Offering of Ordinary Shares and Pre-Funded Warrants

24/09/2024 - 22:01

CAMBRIDGE, Mass., Sept. 24, 2024 (GLOBE NEWSWIRE) -- Wave Life Sciences Ltd. (Nasdaq: WVE), a clinical-stage biotechnology company focused on unlocking the broad potential of RNA medicines to transform human health, [...]

Highmark, US Digestive Health Reach New Contract Agreement

24/09/2024 - 21:08

PITTSBURGH and EXTON, Pa., Sept. 24, 2024 (GLOBE NEWSWIRE) -- Highmark and US Digestive Health have announced that the two organizations reached agreement on a new five-year contract that ensures long-term, in-network [...]

ZKR Orthopedics Performs First U.S. Patella Lift Procedure Initiating FDA Trial

24/09/2024 - 19:00

New Method for the Treatment of Patellofemoral Arthritis SAN FRANCISCO, Sept. 24, 2024 (GLOBE NEWSWIRE) -- ZKR Orthopedics, Inc., a leader in innovative orthopedic solutions, today announced the successful performance [...]

Sharps Technology, Inc. Closes $3.5 Million Bridge Financing

24/09/2024 - 18:58

NEW YORK, Sept. 24, 2024 (GLOBE NEWSWIRE) -- Sharps Technology, Inc. (NASDAQ: STSS) (the “Company”), an innovative medical device and pharmaceutical packaging company offering patented, best-in-class syringe products, [...]

EssilorLuxottica: Déclaration de transactions sur actions propres

24/09/2024 - 18:00

Déclaration de transactions sur actions propres Paris, France (24 septembre 2024, 18h00) – Conformément à l’autorisation octroyée par l’Assemblée Générale du 30 avril 2024, EssilorLuxottica déclare que du 17 septembre [...]

CARBIOS and Selenis announce strategic partnership to produce PETG issued from CARBIOS’ biorecycling technology for Cosmetic and Healthcare markets

24/09/2024 - 18:00

Clermont-Ferrand (France), Tuesday 24 September 2024 (6pm CEST). - CARBIOS , (Euronext Growth Paris : ALCRB), a pioneer in the development and industrialization of biological technologies to reinvent the life cycle of [...]

CARBIOS et Selenis annoncent un partenariat stratégique pour la production de PETG issu de la technologie de biorecyclage de CARBIOS pour les marchés de la cosmétique et de la santé

24/09/2024 - 18:00

Clermont-Ferrand (France), le mardi 24 septembre 2024 (18h00 CEST) : CARBIOS (Euronext Growth Paris: ALCRB), pionnière dans le développement et l'industrialisation de technologies biologiques pour réinventer le cycle de [...]